Clinical Trial Update: Therapy in Amyotrophic Lateral Sclerosis (TAME) [Phase 2]

View source ↗

Summary

Phase 2 trial update for a therapy in amyotrophic lateral sclerosis and frontotemporal dementia; trial completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Frontotemporal Dementia

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia | Phase 2 | Status: COMPLETED | Results posted: 2022-11-29